Drug Profile
Research programme: GABA receptor A modulators - Ferrer
Alternative Names: GF-009549-00Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Ferrer
- Class
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Insomnia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Insomnia in Spain
- 15 Jan 2009 Preclinical development is ongoing in Spain
- 31 Aug 2006 Preclinical trials in Insomnia in Spain (unspecified route)